Blue Sail Medical Co Ltd (002382) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Blue Sail Medical Co Ltd (002382) has a cash flow conversion efficiency ratio of -0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-63.13 Million ≈ $-9.24 Million USD) by net assets (CN¥9.71 Billion ≈ $1.42 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Blue Sail Medical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Blue Sail Medical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Blue Sail Medical Co Ltd for a breakdown of total debt and financial obligations.
Blue Sail Medical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Blue Sail Medical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Netcare
JSE:NTC
|
0.220x |
|
Karoon Energy Ltd
AU:KAR
|
0.165x |
|
SFL Corporation Ltd
NYSE:SFL
|
0.067x |
|
Jiangsu Transimage Technology Co Ltd
SHE:002866
|
0.011x |
|
Trican Well Service Ltd.
TO:TCW
|
0.127x |
|
Oric Pharmaceuticals Inc
NASDAQ:ORIC
|
-0.058x |
|
SBFC Finance Limited
NSE:SBFC
|
-0.243x |
|
T1 Energy Inc.
NYSE:TE
|
0.410x |
Annual Cash Flow Conversion Efficiency for Blue Sail Medical Co Ltd (2006–2024)
The table below shows the annual cash flow conversion efficiency of Blue Sail Medical Co Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see Blue Sail Medical Co Ltd (002382) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥9.80 Billion ≈ $1.43 Billion |
CN¥135.85 Million ≈ $19.88 Million |
0.014x | +281.59% |
| 2023-12-31 | CN¥9.55 Billion ≈ $1.40 Billion |
CN¥-72.89 Million ≈ $-10.67 Million |
-0.008x | -116.29% |
| 2022-12-31 | CN¥10.55 Billion ≈ $1.54 Billion |
CN¥494.47 Million ≈ $72.36 Million |
0.047x | -78.01% |
| 2021-12-31 | CN¥10.54 Billion ≈ $1.54 Billion |
CN¥2.25 Billion ≈ $328.59 Million |
0.213x | -43.01% |
| 2020-12-31 | CN¥9.82 Billion ≈ $1.44 Billion |
CN¥3.67 Billion ≈ $537.26 Million |
0.374x | +304.35% |
| 2019-12-31 | CN¥8.46 Billion ≈ $1.24 Billion |
CN¥782.79 Million ≈ $114.55 Million |
0.092x | +11.09% |
| 2018-12-31 | CN¥7.80 Billion ≈ $1.14 Billion |
CN¥649.37 Million ≈ $95.02 Million |
0.083x | -47.75% |
| 2017-12-31 | CN¥1.43 Billion ≈ $209.01 Million |
CN¥227.57 Million ≈ $33.30 Million |
0.159x | +26.35% |
| 2016-12-31 | CN¥1.30 Billion ≈ $190.24 Million |
CN¥163.93 Million ≈ $23.99 Million |
0.126x | -42.87% |
| 2015-12-31 | CN¥1.18 Billion ≈ $173.22 Million |
CN¥261.30 Million ≈ $38.24 Million |
0.221x | +52.92% |
| 2014-12-31 | CN¥1.05 Billion ≈ $153.03 Million |
CN¥150.96 Million ≈ $22.09 Million |
0.144x | +6.12% |
| 2013-12-31 | CN¥984.34 Million ≈ $144.04 Million |
CN¥133.89 Million ≈ $19.59 Million |
0.136x | -14.95% |
| 2012-12-31 | CN¥961.83 Million ≈ $140.75 Million |
CN¥153.82 Million ≈ $22.51 Million |
0.160x | +322.70% |
| 2011-12-31 | CN¥916.68 Million ≈ $134.14 Million |
CN¥-65.83 Million ≈ $-9.63 Million |
-0.072x | -105.01% |
| 2010-12-31 | CN¥903.72 Million ≈ $132.24 Million |
CN¥-31.66 Million ≈ $-4.63 Million |
-0.035x | -111.47% |
| 2009-12-31 | CN¥203.26 Million ≈ $29.74 Million |
CN¥62.05 Million ≈ $9.08 Million |
0.305x | -36.30% |
| 2008-12-31 | CN¥158.41 Million ≈ $23.18 Million |
CN¥75.91 Million ≈ $11.11 Million |
0.479x | +189.28% |
| 2007-12-31 | CN¥97.05 Million ≈ $14.20 Million |
CN¥16.08 Million ≈ $2.35 Million |
0.166x | +8.71% |
| 2006-12-31 | CN¥78.81 Million ≈ $11.53 Million |
CN¥12.01 Million ≈ $1.76 Million |
0.152x | -- |
About Blue Sail Medical Co Ltd
Blue Sail Medical Co.,Ltd. operates as a medical device company in China and internationally. It operates through Health Protection Division; Cardiovascular and Cerebrovascular Department; and Emergency Rescue Division segments. The company offers cardiovascular and cerebrovascular products comprising drug-eluting stents and balloons, conventional balloons, and transcatheter aortic valve replacem… Read more